Please login to the form below

Not currently logged in
Email:
Password:

Latuda

This page shows the latest Latuda news and features for those working in and with pharma, biotech and healthcare.

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

The deal is good news for both parties – Sumitomo needs new products ahead of the loss of its US patent for its star schizophrenia drug Latuda, and it will help Roivant

Latest news

  • EU approval for Takeda’s schizophrenia drug EU approval for Takeda’s schizophrenia drug

    Takeda and development partner Dainippon Sumitomo Pharma have won European approval for their schizophrenia treatment Latuda (lurasidone). ... Smith previously described Latuda as a potential blockbuster in an interview with PMLiVE.

  • GSK's diabetes drug among CHMP recommendations GSK's diabetes drug among CHMP recommendations

    s antipsychotic Latuda and Linepharma France's Hemoprostol for haemorrhage in women. ... 2013. Takeda's antipsychotic and Linepharma's Hemoprostol. Elsewhere in the CHMP opinions, Takeda received a recommendation for the use of Latuda (lurasidone) in the

  • Coronary conundrums

    US. Lurasidone. Latuda (Sunovion Pharmaceuticals). Schizophrenia. US an Puerto Rico. Paracetamol.

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics